Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 147

1.

The IARC commitment to cancer prevention: the example of papillomavirus and cervical cancer.

Franceschi S.

Recent Results Cancer Res. 2005;166:277-97. Review.

PMID:
15648196
[PubMed - indexed for MEDLINE]
2.

Quadrivalent Human Papillomavirus Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP).

Markowitz LE, Dunne EF, Saraiya M, Lawson HW, Chesson H, Unger ER; Centers for Disease Control and Prevention (CDC); Advisory Committee on Immunization Practices (ACIP).

MMWR Recomm Rep. 2007 Mar 23;56(RR-2):1-24.

PMID:
17380109
[PubMed - indexed for MEDLINE]
Free Article
3.

New concepts on risk factors of HPV and novel screening strategies for cervical cancer precursors.

Syrjänen K.

Eur J Gynaecol Oncol. 2008;29(3):205-21.

PMID:
18592782
[PubMed - indexed for MEDLINE]
4.

[What should be known for the introduction of an HPV vaccine?].

Muñoz N, Jacquard AC.

Presse Med. 2008 Oct;37(10):1377-90. doi: 10.1016/j.lpm.2008.04.008. Epub 2008 Sep 10. Review. French.

PMID:
18786806
[PubMed - indexed for MEDLINE]
5.

Human papilloma virus (HPV) prophylactic vaccination: challenges for public health and implications for screening.

Adams M, Jasani B, Fiander A.

Vaccine. 2007 Apr 20;25(16):3007-13. Epub 2007 Jan 18. Review.

PMID:
17292517
[PubMed - indexed for MEDLINE]
6.

[Human papillomavirus and carcinoma of the cervix vaccines against the human papillomavirus-promise of an efficacious prevention].

Kohl I.

Klin Mikrobiol Infekc Lek. 2006 Jun;12(3):91-7. Review. Czech.

PMID:
17051469
[PubMed - indexed for MEDLINE]
7.

Worldwide human papillomavirus etiology of cervical adenocarcinoma and its cofactors: implications for screening and prevention.

Castellsagué X, Díaz M, de Sanjosé S, Muñoz N, Herrero R, Franceschi S, Peeling RW, Ashley R, Smith JS, Snijders PJ, Meijer CJ, Bosch FX; International Agency for Research on Cancer Multicenter Cervical Cancer Study Group.

J Natl Cancer Inst. 2006 Mar 1;98(5):303-15.

PMID:
16507827
[PubMed - indexed for MEDLINE]
Free Article
8.

Chapter 3: Cofactors in human papillomavirus carcinogenesis--role of parity, oral contraceptives, and tobacco smoking.

Castellsagué X, Muñoz N.

J Natl Cancer Inst Monogr. 2003;(31):20-8. Review.

PMID:
12807941
[PubMed - indexed for MEDLINE]
9.

[Human papilloma virus and cervical cancer].

Berumen-Campos J.

Gac Med Mex. 2006 Sep-Oct;142 Suppl 2:51-9. Spanish.

PMID:
19031679
[PubMed - indexed for MEDLINE]
10.

Cervical cancer: screening and prevention.

Behtash N, Mehrdad N.

Asian Pac J Cancer Prev. 2006 Oct-Dec;7(4):683-6. Review.

PMID:
17250453
[PubMed - indexed for MEDLINE]
Free Article
11.

[Vaccination against human papillomavirus for the prevention of cervical cancer].

Quint WG, ter Harmsel WA, van Doorn LJ.

Ned Tijdschr Geneeskd. 2006 Jun 24;150(25):1380-4. Review. Dutch.

PMID:
16841585
[PubMed - indexed for MEDLINE]
12.

Cervical cancer and human papillomavirus: epidemiological evidence and perspectives for prevention.

Muñoz N, Bosch FX.

Salud Publica Mex. 1997 Jul-Aug;39(4):274-82.

PMID:
9337560
[PubMed - indexed for MEDLINE]
13.

The impact of anti HPV vaccination on cervical cancer incidence and HPV induced cervical lesions: consequences for clinical management.

Brinkman JA, Caffrey AS, Muderspach LI, Roman LD, Kast WM.

Eur J Gynaecol Oncol. 2005;26(2):129-42. Review.

PMID:
15857016
[PubMed - indexed for MEDLINE]
14.

Human papillomavirus, cervical cancer, and the vaccines.

Tovar JM, Bazaldua OV, Vargas L, Reile E.

Postgrad Med. 2008 Jul;120(2):79-84. doi: 10.3810/pgm.2008.07.1794. Review.

PMID:
18654072
[PubMed - indexed for MEDLINE]
15.

Integrating human papillomavirus vaccination in cervical cancer control programmes.

Franco EL, Coutlée F, Ferenczy A.

Public Health Genomics. 2009;12(5-6):352-61. doi: 10.1159/000214925. Epub 2009 Aug 11. Review.

PMID:
19684447
[PubMed - indexed for MEDLINE]
16.

A review of cross-protection against oncogenic HPV by an HPV-16/18 AS04-adjuvanted cervical cancer vaccine: importance of virological and clinical endpoints and implications for mass vaccination in cervical cancer prevention.

Jenkins D.

Gynecol Oncol. 2008 Sep;110(3 Suppl 1):S18-25. doi: 10.1016/j.ygyno.2008.06.027. Epub 2008 Jul 23. Review.

PMID:
18653221
[PubMed - indexed for MEDLINE]
17.

[Prevention of cervical cancer (II): prophylactic HPV vaccination, current knowledge, practical procedures and new issues].

Monsonego J.

Presse Med. 2007 Apr;36(4 Pt 2):640-66. Epub 2007 Mar 12. Review. French. Erratum in: Presse Med. 2007 Jul-Aug;36(7-8):1150-1.

PMID:
17350792
[PubMed - indexed for MEDLINE]
18.

Prophylactic vaccination against human papillomavirus infection and disease in women: a systematic review of randomized controlled trials.

Rambout L, Hopkins L, Hutton B, Fergusson D.

CMAJ. 2007 Aug 28;177(5):469-79. Epub 2007 Aug 1. Review.

PMID:
17671238
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

HPV vaccination against cervical cancer in women above 25 years of age: key considerations and current perspectives.

Castellsagué X, Schneider A, Kaufmann AM, Bosch FX.

Gynecol Oncol. 2009 Dec;115(3 Suppl):S15-23. doi: 10.1016/j.ygyno.2009.09.021. Epub 2009 Oct 12.

PMID:
19819540
[PubMed - indexed for MEDLINE]
20.

Cervical carcinoma in Algiers, Algeria: human papillomavirus and lifestyle risk factors.

Hammouda D, Muñoz N, Herrero R, Arslan A, Bouhadef A, Oublil M, Djedeat B, Fontanière B, Snijders P, Meijer C, Franceschi S.

Int J Cancer. 2005 Jan 20;113(3):483-9.

PMID:
15455386
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk